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Leptomeningeal dissemination (LMD), the metastatic spread of tumor cells via the cerebrospinal fluid to the brain
and spinal cord, is an ominous prognostic sign for patients with the pediatric brain tumor medulloblastoma. The
need to reduce the risk of LMD has driven the development of aggressive treatment regimens, which cause disabling
neurotoxic side effects in long-term survivors. Transposon-mediated mutagenesis studies in mice have revealed
numerous candidate metastasis genes. Understanding how these genes drive LMD will require functional assessment
using in vivo and cell culture models of medulloblastoma. We analyzed two genes that were sites of frequent
transposon insertion and highly expressed in human medulloblastomas: Arnt (aryl hydrocarbon receptor nuclear
translocator) and Gdi2 (GDP dissociation inhibitor 2). Here we show that ectopic expression of Arnt and Gdi2 promoted
LMD in mice bearing Sonic hedgehog (Shh)-induced medulloblastomas. We overexpressed Arnt and Gdi2 in a human
medulloblastoma cell line (DAOY) and an immortalized, nontransformed cell line derived from mouse granule neuron
precursors (SHH-NPD) and quantified migration, invasiveness, and anchorage-independent growth, cell traits that
are associated with metastatic competence in carcinomas. In SHH-NPD cells. Arnt and Gdi2 stimulated all three
traits. In DAOY cells, Arnt had the same effects, but Gdi2 stimulated invasiveness only. These results support a
mechanism whereby Arnt and Gdi2 cause cells to detach from the primary tumor mass by increasing cell motility
and invasiveness. By conferring to tumor cells the ability to proliferate without surface attachment, Arnt and Gdi2
favor the formation of stable colonies of cells capable of seeding the leptomeninges.
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An important goal in designing therapies for patients with
the malignant brain tumor medulloblastoma is to reduce
the risk of metastasis. A defining characteristic of metasta-
sis in medulloblastoma is leptomeningeal dissemination
(LMD), the spread of tumor cells via the cerebrospinal
fluid (CSF) to the leptomeningeal spaces of the brain
and spinal cord. The need to minimize metastasis risk
is critical because survival times are very low once
LMD has occurred. Guided by this principle, pediatric
oncologists have designed multimodality treatments,
which combine surgery, chemotherapy, and craniospinal
radiation [1,2]. These aggressive regimens reduce the risk* Correspondence: daniel.fults@hsc.utah.edu
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unless otherwise stated.of metastasis, but they are associated with disabling side
effects, including neuropsychiatric challenges, stunted
body growth, hormonal imbalance, epilepsy, and stroke
in long-term survivors [3-5].
Because the prospect for long-term survival is so poor
for patients with LMD, radiation to the entire neuraxis
remains an indispensable part of medulloblastoma treat-
ment. Unfortunately, intellectual capacity and academic
achievement decline even in children treated with protocols
that use reduced radiation doses [6]. Hope for prolonging
disease-free survival and eliminating treatment-related neu-
rotoxicity rests on developing therapies that specifically
target the molecular mediators of LMD, our knowledge
of which is limited.
Analysis of the medulloblastoma transcriptome in large
cohorts of patients has shown that medulloblastomasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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diverse set of tumors, which have different gene expression
profiles, rates of metastatic dissemination, and patient
survival times [7-9]. Despite the identification of molecular
signatures with prognostic implications, metastasis stage
remains a critical determinant of high-risk tumors [10].
The expression signature of most common medullo-
blastoma subtype affecting infants and adults implicates
the Sonic Hedgehog (Shh) signaling pathway in tumor
pathogenesis. Shh signaling, which governs many aspects
of embryogenesis, stimulates proliferation and inhibits
differentiation of neural progenitor cells in the cerebellum
[11]. Consistent with this developmental function, genetic-
ally engineered mouse models have shown that aberrant
activation of the Shh pathway in either multipotent neural
stem cells or granule neuron precursor cells (GNPs) in
the developing cerebellum can initiate medulloblastoma
formation [12-17].
We reported previously that ectopic expression of genes
encoding Eras (embryonic stem cell–expressed Ras), Lhx1
(LIM-class homeobox gene 1), Ccrk (cell cycle–related
kinase), and the phosphatidyl inositol 3-kinase signaling
protein Akt shifted the growth characteristics of Shh-
induced medulloblastoma from a localized pattern to
one in which tumor cells seeded the leptomeninges of
the brain and spinal cord [18]. The idea that these proteins
might be LMD drivers came from a screen for metas-
tasis genes using transposon-mediated mutagenesis in
Patched-deficient mice, which develop medulloblastomas
spontaneously [19].
Extensive evidence from the field of epithelial cancer
metastasis indicates that a large number of genes choreo-
graph the multistep process whereby tumor cells breach
the basement membrane in the originating tissue, intrava-
sate into the bloodstream, and colonize distant organs
[20,21]. Although the chain of events involved in LMD
is different from the invasion-metastasis cascade of
carcinomas, the changes in cell physiology needed for
medulloblastoma cells to detach from the tumor mass,
enter the CSF, and proliferate in the subarachnoid
spaces no doubt require an equivalently diverse set of
genes.
To expand the set of LMD-driving genes, we transferred
and expressed Arnt (aryl hydrocarbon receptor nuclear
translocator) and Gdi2 (GDP dissociation inhibitor 2),
which had been identified previously as common insertion
sites for the Sleeping Beauty (SB) transposon, in cerebellar
neural progenitor cells in mice by retroviral transfer in
combination with Shh. Here we show that ectopic ex-
pression of Arnt and Gdi2 promotes spinal LMD in mice
bearing Shh-induced medulloblastomas and demonstrate
the effects of these genes on the motility, invasiveness,
and anchorage-independent growth of medulloblastoma
tumor cells and precursor cells in culture.Materials and methods
Retroviral vector construction
Construction of RCAS-Shh, which contains an in-frame,
carboxy-terminal epitope tag consisting of six repeats of
the influenza virus hemagglutinin (HA) epitope, was de-
scribed previously [14]. The cDNA clones for mouse
Arnt and Gdi2 were obtained from the American Type
Culture Collection (Manassas, VA), where they were de-
posited by the Integrated Molecular Analysis of Genomes
and their Expression (IMAGE) consortium (http://www.
imageconsortium.org). RCAS vectors were prepared by
ligating a PCR-generated cDNA corresponding to the
complete coding sequence into the parent retroviral
vector RCASBP(A) [22]. RCAS-Gdi2 contained an in-
ternal ribosome entry site (IRES) coupled to the Aequorea
coerulescens green fluorescent protein (GFP) for tracking
the cellular localization of the expressed proteins. To pro-
duce live virus, we transfected plasmid versions of RCAS
vectors into immortalized chicken fibroblasts (DF-1 cells)
and allowed them to replicate in culture.
In vivo somatic cell gene transfer in transgenic mice
The use of mice in this study was approved by the Institu-
tional Animal Care and Use Committee of the University
of Utah. To induce medulloblastomas in mice, we used
a version of the RCAS/tv-a somatic cell gene transfer
system to transfer and express the Shh gene in Nestin-
expressing cells in the cerebellum. Nestin, an intermediate
filament protein, is a marker for neural progenitor cells
prior to neuronal or glial differentiation. The RCAS/tv-a
system uses a replication-competent, avian leukosis virus,
splice acceptor (RCAS) vector, derived from the subgroup
A avian leukosis virus (ALV-A), and a transgenic mouse
line (Ntv-a) that produces TVA (the cell surface receptor
for ALV-A) under control of the Nestin gene promoter
[23]. After TVA-mediated infection of mammalian cells
with RCAS retrovirus, the newly synthesized provirus
integrates into the host cell genome where the transferred
gene is expressed constitutively. RCAS-transduced mam-
malian cells do not produce infectious virus because
mRNA splicing events remove the retroviral genes ne-
cessary for viral replication.
To initiate gene transfer, we injected retrovirus pack-
aging cells (DF-1 cells transfected with and producing
recombinant RCAS retrovirus) into the lateral cerebellum
of the mouse from an entry point just posterior to the
lambdoid suture of the skull (bilateral injections of 105
cells in 1–2 μl of phosphate buffered saline (PBS)). For
experiments involving simultaneous transfer of two genes,
we prepared cell pellets by mixing equal numbers of both
retrovirus-producing cells. We injected mice within 72
hours after birth because the number of Nestin+ cells
decreases progressively during the course of neuronal
differentiation. The mice were sacrificed when signs of
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by enlarging head circumference (a sign of hydrocephalus),
head tilt, gait ataxia, or failure to eat or drink. Asymptom-
atic mice were sacrificed 4 months after injection. The
brains were fixed in formalin, and divided into quarters
by parallel incisions in the coronal plane. To identify
spinal LMD, we fixed whole spinal column preparations
in formalin for 48–72 hours and then removed the
spinal cord by microdissection. Brain and spinal cord
specimens were embedded in paraffin and sectioned for
histochemical analysis.
Immunocytochemistry and microscopy
Methods for immunoperoxidase staining of mouse brain
and spinal cord sections were described previously
[18]. We used the following antibodies from the indi-
cated commercial sources: Mab9E10—c-Myc (Santa
Cruz Biotechnology, Santa Cruz, CA); Mab3580—GFP
(Chemicon, Temecula, CA); ab14545—βIII-tubulin (Abcam,
Cambridge, MA); Mab2F11—70 kDa neurofilament protein
(Dako, Carpinteria, CA). Tissue sections were visualized
using a Zeiss Axiovert 200 microscope, and photomicro-
graphs were captured using an AxioCam high-resolution
CCD camera and Axiovision imaging software (Carl Zeiss
International, Germany).
Gene transfer by lentivirus
To express Arnt and Gdi2 in cultured cells, we used the
HIV-ZsGreen lentivirus system [24]. The gene-transfer
plasmid (pHIV-ZsGreen, Addgene plasmid 18121) encodes
a GFP from the reef coral Zoanthus to track expression of
the transgene in infected cells. To produce live virus for
gene transfer, we ligated Arnt and Gdi2 cDNAs into
the NotI-XbaI site of pHIV-ZsGreen and transferred
the recombinant plasmids to HEK293T packaging cells
by transfection in combination with helper plasmids
pMDLgRRE, pRSV-Rev, and pCMV-VSV-G. Virus parti-
cles were collected by ultracentrifugation and applied to
recipient cells in tissue culture plates under biosafety level
2 conditions. Viral titer was determined from the ratio of
fluorescent to nonfluorescent cells.
In vitro scratch assay
SHH-NPD or DAOY cells, previously infected with HIV-
ZsGreen lentivirus and expressing Arnt or Gdi2, were
seeded into 6-well plates (35-mm well diameter) in trip-
licate and incubated at 37°C under 5% CO2 until the cell
density reached 90% confluence. The cells were washed
with PBS and incubated overnight in serum-free Dulbecco’s
modified Eagle medium (DMEM) containing 10 μg/ml
mitomycin C to suppress proliferation. A linear wound
was created in the nearly confluent cell monolayer by
scratching across the center of the plate using a sterile
200-μl pipette tip in a smooth, even fashion, and themedium was replaced with DMEM containing 10% fetal
bovine serum. Digital photomicrographs were taken 0
and 10 hours after making the scratch wound through
a 10× phase contrast microscope objective. Prior to
each photo session, the medium was replaced with PBS
to obtain a clear photographic image. To quantify the rate
of cell migration across the wound gap, we measured
the distance between the two advancing, converging
cell fronts at five points equidistant along the scratch
wound. The rate of cell migration (μm/hour) was calculated
using the following formula: [average scratch width at 0
hours − average scratch width at 10 hours] ÷ 20. The
denominator of 20 is used to account for the ten hours
of observation and two advancing cell fronts. Each
experiment was repeated on a separate day. Standard
deviation (SD) for the mean migration rate was derived
from 30 data points.
Matrigel chemoinvasion assay
SHH-NPD or DAOY cells (2 × 105), previously infected
with HIV-ZsGreen lentivirus and expressing Arnt or
Gdi2, were plated into the upper chamber of an 8-μm,
6-well BD Biocoat Matrigel invasion chamber (BD
Biosciences, Bradford, MA) in 500 μl of serum-free DMEM.
Prior to plating, the cells were treated with 10 μg/ml
mitomycin C to suppress proliferation. Each bottom
chamber was filled with 2 ml of DMEM containing 10%
fetal bovine serum and then incubated for 24 hours at
37°C under 10% CO2. After incubation, the noninvading
cells are removed from the upper chamber with a cotton
swab. The invading cells on the lower surface of the
membrane were stained with Hema 3 (Fisher Scientific,
Loughborough, UK) and counted under a microscope.
Five nonoverlapping microscope fields (10× objective)
were counted in each well. Each assay was repeated,
and the mean number of invading cells per well was
calculated. SD was derived from 20 data points.
Soft agar colony forming assay
Cells (104) were suspended in culture medium (2 ml)
containing 0.3% agar (Difco Bactoagar, Detroit, MI) and
plated over a layer of 0.5% agar in the same culture
medium in tissue culture plates (35 mm in diameter).
Triplicate cultures were incubated at 37°C under 5%
CO2. Colonies were counted 14 days after plating by
viewing under a microscope through a 10× objective and
a graduated eyepiece reticle. Any colonies larger than
38 μm in diameter (>10 cells) were scored as positive.
SD was derived from three data points.
Reverse transcriptase–polymerase chain reaction (RT-PCR)
Cerebella were removed from euthanized mice and frozen
immediately in liquid nitrogen. Tissue specimens were
homogenized in Trizol, and total RNA was extracted
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to the manufacturer’s instructions. RT-PCR was carried
out using the SuperScript III One-Step RT-PCR kit (Life
Technologies, Grand Island, NY) as described previously
[25]. In brief, cDNA was synthesized from total RNA by
reverse transcription and PCR in the presence of oligo-
nucleotide primers specific for Myc epitope–tagged Arnt.
RT-PCR products corresponding to the constitutively
expressed, glycolytic enzyme glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) served as internal controls for
sample variation in mRNA degradation and gel loading.
Reaction products were separated by electrophoresis
through agarose gels and visualized by UV illumination
after immersion in ethidium bromide solution.Figure 1 SB transposon insertions in Arnt and Gdi2. A, For cancer
gene identification, the SB transposon is designed to mimic retroviral
insertional mutagenesis. The transposon contains sequences from the 5’
long terminal repeat (LTR) of murine stem cell virus (MSCV) which serve
as promoter/enhancer elements to activate transcription of genes into
which the transposon has inserted. The MSCV LTR is followed by a splice
donor (SD). Thus, a transcript initiated in the LTR (mRNA1) can splice into
downstream exons of the target gene. The transposon also contains
splice acceptor (SA) sites and polyadenylation (pA) sequences to
truncate transcription of target genes (mRNA2). The SB transposon
schematized here is the T2/Onc vector [29]. B, Insertion maps showing
the sites of transposon insertion (arrowheads) in mouse genes Arnt and
Gdi2. Arrow heads point in the direction of transcription from the MSCV
LTR. Transcription-activating insertions in the 5’ untranslated region and
intron 1 are indicated by solid arrowheads. Coding exons are represented
by vertical lines, introns by the interval spaces. Right-angle arrows
indicate the direction of gene transcription.Expression profiling and molecular subgrouping of
human medulloblastomas
Human primary medulloblastomas were profiled on
Affymetrix Genechip Human Exon 1.0ST arrays at The
Centre for Applied Genomics in Toronto, Canada (www.
tcag.ca). Expression analysis was performed using Affy-
metrix Expression Console (Version 1.1) as previously
described [26]. Additional, publically available medullo-
blastoma expression data sets were obtained from NCBI
Gene Expression Omnibus and used to validate our find-
ings [9,27]. Subgrouping of tumors was performed using
an 84-gene expression classifier [28].
Statistics
We assessed statistical significance of intergroup differences
in cell migration, invasion, and anchorage-independent
growth using ANOVA and Fisher’s protected least sig-
nificant difference test. The significance of intergroup
differences in the incidence of tumor formation and
LMD was assessed using the χ2 contingency test.
Results
Sleeping Beauty transposon mutagenesis identifies Arnt
and Gdi2 as common insertion site genes in metastatic
medulloblastomas
Arnt and Gdi2 emerged as candidate LMD-inducing
genes from a study in which SB transposon mobilization
in Math1+ GNPs in Patched+/− mice caused the typically
localized, Shh-driven medulloblastomas to disseminate
widely throughout the spinal leptomeninges [19]. The
SB transposon (Figure 1A) is designed to promote tumor
growth by either enhancing transcription of proto-onco-
genes or suppressing transcription of tumor suppressor
genes located at insertion sites (reviewed in [29]). Candidate
LMD genes were identified by sequencing the insertion
sites from spinal metastatic tumors and matched cerebellar
tumors and then mapping the sequences back to the
mouse genome. This approach revealed 359 gene-centriccommon insertion sites (gCISs), in which the transposon
had inserted more frequently than a calculated back-
ground level of random insertion.
To identify the strongest LMD driver genes, we first
focused on the 285 gCISs that were present either
exclusively in the spinal metastatic tumors or in both
the primary tumors and matched metastases. This cri-
terion was used to identify genes whose expression
putatively conferred a growth advantage to tumor cells
in the microenvironment of the spinal cord. Second, we
examined the transposon insertion maps to identify
genes whose transcription was most likely stimulated
by transposon integration (metastasis-promoting onco-
genes). These were genes in which (a) the SB transposon
had inserted into the 5’ untranslated region or intron I
and (b) the murine stem cell virus promoter of the SB
transposon pointed in the direction of gCIS-associated
gene transcription. Two such insertions occurred in Arnt
and four in Gdi2 (Figure 1B, solid arrowheads).
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Shh-induced medulloblastomas
The high frequency of SB transposon insertions in Arnt
and Gdi2 indicated that activated transcription of these
genes plays a causal role in the LMD program. To test
this hypothesis, we used an established mouse model
system, in which retroviral transfer of Shh to Nestin+
neural progenitor cells in the cerebella of mice induces
medulloblastomas that have a very low incidence of
metastatic dissemination [18]. Using this system, we trans-
ferred and expressed Arnt and Gdi2, in combination with
Shh, in the cerebella of newborn mice and examined
histological sections of brain and spinal cord in a 4-month
observation period. Our results demonstrated that
Arnt and Gdi2 increased the incidence of spinal LMD
(Figure 2A,B), as a percentage of mice with histologically
verified tumors in the cerebellum, from a baseline of 17%
(Shh alone) to 67% (Shh + Arnt) and 53% (Shh + Gdi2)
(Table 1). The enhancing effect of Arnt on spinal LMD
was more potent than we reported previously withFigure 2 Histopathology of leptomeningeal dissemination. A, Aggrega
cord. B, Tumor cells (arrow) attached to the conus medullaris in the lumbar sp
with molded nuclei and mitotic figures. D, Medulloblastoma in the cerebellum
brain stem (arrow). E, Disseminating tumor cells in the subependymal space o
F, Nodule of disseminating tumor in the wall of the temporal horn of the late
A–E, Shh + Arnt–induced tumors. F, Shh + Gdi2–induced tumors. Scale bar, 25Eras, Lhx1, Ccrk, and Akt, whereas that of Gdi2 was
comparable [18].
The incidence of tumor formation in the cerebellum
was equivalent in Shh, Shh +Arnt, and Shh +Gdi2 groups
(Table 1), indicating that these genes were conferring to
tumor cells specific dissemination-enabling traits, rather
than simply increasing the number of susceptible cells
through enhanced tumor initiation. Addition of Arnt
and Gdi2 did not alter the classical cytoarchitecture of
Shh-induced medulloblastomas, which is characterized
by densely packed sheets of cells with nuclear molding
and scant cytoplasm (Figure 2C).
In the clinical setting, spinal LMD is often accompanied
by extension of the primary tumor to brain surfaces inside
the posterior cranial fossa and to subarachnoid spaces in
the forebrain. Accordingly, we observed in mouse medul-
loblastomas induced by Shh + Arnt and Shh +Gdi2 that
tumor cells had spread outside the cerebellum to the
leptomeningeal surfaces of the brain stem (Figure 2D) and
subependymal spaces of the lateral ventricles (Figure 2E,F).tes of medulloblastoma cells on the pial surface of the thoracic spinal
ine. C, Classic medulloblastoma cytoarchitecture showing tumor cells
spreading into the adjacent fourth ventricle and leptomeninges of the
f the lateral ventricle. Ciliated ependymal cells are visible at the top.
ral ventricle. The dentate gyrus of the hippocampus is visible below.
μm (A–C), 16 μm (E), 500 μm (D and F).
Table 1 Incidence of medulloblastoma formation and
leptomeningeal dissemination (LMD) during a 4-month
observation period
Genes transferred Tumor Incidence P value* (spine)
Cerebellum Spine LMD†
Shh 23 of 48 (48%) 4 of 23 (17%) –
Shh + Arnt 27 of 69 (39%) 18 of 27 (67%) 0.0005
Shh + Gdi2 15 of 46 (33%) 8 of 15 (53%) 0.02
*P values were calculated using χ2 contingency test to compare spine tumor
incidence after combined gene transfer with tumor incidence after transfer of
Shh alone.
†Spine tumor incidence calculated as a percentage of mice with histologically
verified brain tumors.
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transferred by RCAS retrovirus, we used the following
approaches. For Gdi2, we demonstrated specific immuno-
staining with an antibody directed against GFP, which
was transcribed in tandem with the inserted oncogene
through an IRES sequence (Figure 3A). The large size
of the Arnt coding sequence (2376 base pairs) excluded the
possibility of constructing an Arnt-IRES-GFP bicistronic
vector. Therefore, we prepared an epitope-tagged version
by appending six repeats of a human c-Myc sequence
(EQKLISEEDL), which is recognized by monoclonal anti-
body 9E10, to the carboxy terminus of Arnt, in-frame with
the coding sequence. The presence of nuclear immunore-
activity in tumor cells indicated that RCAS-transferred
Arnt was being expressed and transported to the nucleus,
as expected for this transcription factor (Figure 3B). We
could not detect RCAS-transferred Arnt or Gdi2 in the
spinal metastases by immunostaining in all mice, possibly
because individual aggregates of metastasizing cells
contained few cells. We could verify that the RCAS-
transferred gene was expressed in larger metastases to
the spinal cord (Figure 3C) and intracranial sites remote
from the cerebellum (Figure 3D).
To provide additional evidence for in vivo expression
of retroviral Arnt, we performed RT-PCR analysis of
cerebellar specimens from six mice that were injected
with RCAS vectors carrying Shh and Myc-tagged Arnt
and then sacrificed at the onset of neurological signs.
We used oligonucleotide primers that spanned a segment
of the Arnt–Myc fusion sequence. A reaction product cor-
responding to Arnt–Myc transgene mRNA was detected in
four specimens (Figure 3E). In two specimens, the band in-
tensity of RT-PCR product was not above the background
of a control PCR, indicating that retroviral transfer and
integration did not lead to transgene expression in all cases.
Arnt and Gdi2 stimulate motility, invasiveness, and
anchorage-independent growth of medulloblastoma cells
and tumor precursors
Considering the LMD-promoting effects of Arnt and
Gdi2, we predicted that these genes would confer totumor cells a set of traits that enable them to detach
from the tumor mass, survive a transit phase in the CSF,
and ultimately colonize the leptomeninges. Three cell
biological traits that are likely prerequisites for tumor cell
detachment and CSF dispersal are migration, invasion,
and anchorage-independent growth, each of which can be
quantified using cell culture assays. Because we wanted to
assess the effects of LMD driver genes on these cell traits
in Shh-induced medulloblastomas, we tested two cell lines
that we considered facsimiles of Shh-driven medulloblas-
tomas and tumor precursors. One was the well-studied,
human medulloblastoma line DAOY, which retains a
responsive Shh signaling axis [30]. The second was an
immortalized, nontransformed cell line derived from
mouse GNPs (SHH-NPD cells).
We created the SHH-NPD cell line by first preparing
GNP cultures from the cerebella of Ntv-a mice on postna-
tal day six, using an established protocol that generates
cultures that are 90% enriched for GNPs [31]. GNPs can
survive in culture for two weeks, but only when exogen-
ous Shh is added to the medium [32]. We then infected
the Nestin+ cells in this culture with an RCAS retrovirus
to express Shh constitutively. SHH-NPD cells proliferate
continuously in serum-containing medium, but they do
not form tumors after subcutaneous injection in athymic
mice or intracerebral implantation in immunocompetent
mice. Reflecting their origin from GNPs, SHH-NPD
cells express βIII-tubulin, a marker of early neuronal
differentiation, but not neurofilament protein or glial
fibrillary acidic protein, markers of terminally differen-
tiated neurons and astrocytes, respectively (Additional
file 1: Figure S1).
To assess cell migration, we used the in vitro scratch
assay, which measures the rate of cell movement across
a gap created in a confluent monolayer of cells growing
on the surface of a tissue culture plate [33]. We overex-
pressed Arnt and Gdi2 in DAOY and SHH-NPD cells
using the HIV-ZsGreen lentivirus expression system [24].
The average rate of cell migration across the scratch
wound was calculated and compared with that of control
cells infected with empty lentivirus (Figure 4A). The mean
migration rate of control DAOY cells (24.6 μm/hr) was
greater than that of SHH-NPD cells (16.8 μm/hr), consist-
ent with the idea that increased motility is a general
feature of transformed cells. Addition of Arnt increased
the migration rate of DAOY and SHH-NPD cells 1.2-fold
and 1.6-fold, respectively (P < 0.0001 by ANOVA for both
cell lines). Gdi2 increased the migration of SHH-NPD
cells 1.2-fold and paradoxically decreased that of DAOY
cells (P < 0.0001 by ANOVA for both cell lines).
To measure invasiveness, we used the matrigel chemo-
invasion assay, in which the percentage of cells invading
through a gel matrix is determined as a function of time.
Because matrigel contains the principal macromolecular
Figure 3 Expression of RCAS retrovirus–transferred Arnt and Gdi2 in tumor cells. A, Immunoperoxidase staining of GFP in the cytoplasm of
Arnt + Gdi2–induced medulloblastoma cells (arrows) verifying expression of retrovirus-transferred Gdi2. B, Immunostaining of medulloblastoma
induced by RCAS-mediated transfer of Myc-tagged Arnt. Monoclonal antibody 9E10 detects expression of retrovirual Arnt protein in the nuclei of
tumor cells (arrows). C, Immunoreactive staining for GFP in the cytoplasm of tumor cells (above) attached to the surface of the spinal cord (below)
indicating expression of retrovirus-transferred Gdi2. D, Nuclear immunoreactivity for Myc-tagged Arnt in disseminating tumor cells (right) infiltrating the
brain stem (left). E, RT-PCR analysis of human Arnt sequences in cerebella from mice injected with RCAS-Shh and RCAS-Arnt (lanes 2–7) and uninjected
mouse (lane 1). Reaction products indicate expression of Arnt-Myc fusion protein from the integrated RCAS provirus (lanes 3–6). In two cases (lanes 2
and 7), band intensity of RT-PCR product was not above the background of a control PCR, indicating that retroviral transfer and integration did not lead
to transgene expression in all cases. Scale bar, 16 μm (A, C–D), 50 μm (B).
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of cells to invade through this barrier has long been
considered a reliable experimental model of the initial step
in metastasis—transgression of the basement membrane
[34]. Results of the chemoinvasion assays showed that
expression of Arnt and Gdi2 enhanced the ability of both
SHH-NPD and DAOY cells to penetrate the matrigel
barrier (Figure 4B). For example, Arnt increased inva-
siveness of SHH-NPD cells 1.6-fold and DAOY cells
two-fold (P < 0.0001 by ANOVA).
A general feature of transformed cells is the ability to
proliferate without attachment to a solid surface (an-
chorage-independent growth). This would seem to be
an essential attribute of disseminating medulloblastoma
cells, which must survive passage through the CSF before
implanting on the pial surfaces of the spinal cord. To
assess anchorage-independent growth, we measured the
efficiency with which DAOY and SHH-NPD cells formedcolonies in soft agar before and after lentivirus-mediated
expression of Arnt and Gdi2 (Figure 4C). The ability of
SHH-NPD cells to proliferate in soft agar was very low
(2 colonies/well), as expected for a nontransformed cell,
whereas expression of Arnt and Gdi2 increased colony
forming efficiency 8-fold and 6-fold, respectively. In the
transformed DAOY cell line, Arnt increased colony for-
mation from a baseline of 32 to 56 cells/well (P = 0.02),
whereas Gdi2 had no significant effect. The ability of Arnt
and Gdi2 to promote anchorage-independent growth is not
derived from a general mitogenic effect because neither
gene stimulated the proliferation of adherent cells when
tested in an MTTcolorimetry assay (data not shown).
Expression of ARNT and GDI2 in human
medulloblastomas
We asked whether increased expression of ARNT and
GDI2 was associated with an increased risk of metastasis
Figure 4 Analysis of migration, invasion, and anchorage-independent growth in DAOY and SHH-NPD cells. A, In vitro scratch assay in which
monolayers of SHH-NPD and DAOY cells, previously infected with HIVZsGreen lentivirus for stable expression of Arnt, were scratched to create a linear
wound and photographed 0 and 10 hours later. The average rate of cell migration (μm/hr) across the wound gap was determined by measuring the
distance between opposing cell fronts. Fluorescence microscopy verified expression of ZsGreen-tagged Arnt and Gdi2 in the migrating cells. Bar graphs
show the mean rate of cell migration (μm/hr) across the gap. B, Matrigel chemoinvasion assay in which SHH-NPD and DAOY cells expressing lentivirus-
transferred Arnt and Gdi2 or empty virus (control) were placed in the upper wells of BD Biocoat Matrigel chambers and the cells invading through the
matrigel to the lower chamber (arrows) were counted. Bar graphs show the mean number of invading cells/microscope field in two separate experiments.
C, Soft agar colony forming assay. Bar graphs show the mean number of colonies (>38 μm) per well (35-mm diameter) 14 days after plating in 0.3% agar.
Error bars, SD. Scale bar, 400 μm. Statistical significance, compared with control, indicated by asterisks (P < 0.05) or “ns” (not significant).
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analyzed two publicly accessible sets of gene expression
data on human medulloblastomas, which had been as-
signed to one of four molecular subgroups (WNT, SHH,
Group 3, and Group 4). Previously published work
showed that metastasis (defined by the presence of micro-
scopic tumor cells in the CSF, radiographically detected
LMD, or metastasis outside of the central nervous system)
was significantly more common in Group 3 (46.5%) and
Group 4 (29.7%) than in the WNT (17.9%) and SHH
(19.1%) subgroups [28]. The patient tumor specimens had
been collected through two multicenter consortia, the
Medulloblastoma Advanced Genomics International
Consortium (MAGIC) [35] and the Children’s Oncology
Group (COG) [7]. Metastasis stage (M-stage) was recorded
for 285 patients in the MAGIC cohort and 189 in COG,
using the five-tiered Chang classification, based on CSF
cytology and magnetic resonance imaging [36].We determined the relative levels of ARNT mRNA in
two sets of patients from the MAGIC cohort: a 103-patient
discovery set, which was divided into four molecular
subgroups (Figure 5A), and a nonoverlapping 285-patient
validation set, which was divided into three non-WNT
subgroups (Figure 5B). An identical comparison was made
among the four tumor subgroups in COG (Additional
file 2: Figure S2). The mean level of ARNT expression
in the tumors was comparable with that of normal fetal
cerebellum. Approximately 5% of medulloblastomas ana-
lyzed in a subgroup–dependent or –independent fashion
showed >1.5-fold increased expression relative to normal
fetal cerebellum.
When we correlated M-stage with ARNT expression
levels in tumor subgroups from the combined MAGIC
and COG series, we found that among 20 patients with
Group 4 tumors, there were more cases of spinal LMD
(M3-stage) in tumors showing high ARNT expression
Figure 5 Expression of ARNT and GDI2 in human medulloblastoma subgroups. Box plots showing relative expression of ARNT (A,B) and
GDI2 (D,E) in normal cerebella (CB; fetal n = 9, adult n = 5) and medulloblastoma samples from the MAGIC consortium profiled on Affymetrix
exon arrays. The 103 medulloblastomas in the discovery set (A,D) and the 285 in a nonoverlapping validation set (B,E) were classified according
to molecular subtype (WNT, SHH, Group 3, Group 4). Log2 expression is a measure of the luminosity of the gene probe signal, corrected for the
background luminosity of each array and normalized using control probes across different arrays. C, Bar graph correlating M-stage with ARNT
mRNA level (high = top quartile; low = bottom quartile) in Group 4 medulloblastomas (n = 200).
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(χ2 P = 0.02) (Figure 5C). We did not see an association
between ARNT expression levels and M-stage for SHH
and Group 3 tumors.
Comparative analysis of GDI2 expression in the human
tumor data sets revealed that GDI2 mRNA levels were
higher in medulloblastomas than in normal adult and
fetal cerebellum (MAGIC discovery and validation data
shown in Figure 5D and E, respectively, and COG data
in Additional file 2: Figure S2). Subgroup analysis showed
that GDI2 expression was highest in SHH tumors, consist-
ent with our experimental results in Shh-induced tumors
in mice. In contrast to ARNT, there was no correlation
between GDI2 expression and M-stage across any of
the molecular subgroups.
An unanswered question is whether expression of LMD-
driving genes increases over time in a subpopulation of
tumor cells, leading to metastatic dissemination at a later
time point. Answering this question will require analyzing
medulloblastoma cells that have already disseminated, a
project that is hindered by the fact that surgical excision
of metastatic tumors is rarely indicated in patients. We
profiled matched pairs of primary and metastatic medullo-
blastomas from eight patients on Affymetrix exon arrays(Additional file 3: Figure S3). ARNT mRNA levels were
increased ≥1.2-fold in metastatic compared with primary
tumors in four patients (50%), and GDI2 in six (75%).
Although this observation is consistent with a selective
growth advantage conferred to cells by ARNT and GDI2,
larger sets of primary-metastatic tumor pairs will be
needed to verify this trend.
Discussion
We show here that ectopic expression of Arnt and Gdi2,
which were identified in an unbiased genetic screen for
metastasis genes using SB transposon mutagenesis, pro-
motes LMD in Shh-induced medulloblastomas in mice.
When overexpressed in cell culture models of Shh-driven
medulloblastomas and tumor precursors, Arnt stimulated
motility, invasiveness, and anchorage-independent growth,
cell traits that are closely associated with metastatic com-
petence in carcinomas. Gdi2 had these same effects on
tumor precursors and simulated invasiveness in fully
transformed medulloblastoma cells.
Although Arnt and Gdi2 have previously been impli-
cated in cancer biology, the molecular mechanisms by
which these proteins cause medulloblastoma cells to
disseminate remain uncertain. Arnt is most widely known
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ner of the hypoxia-inducible transcription factors HIF1α
and HIF2α, whose downstream target genes play active
roles in angiogenesis, proliferation, invasion, and metasta-
sis (reviewed in [37]). Arnt occupies a second sphere of
biology through its interaction with the aryl hydrocarbon
receptor (AhR), which binds dioxin and other xenobiotics.
After binding a xenobiotic molecule, AhR translocates
from its normal location in the cytoplasm to the nucleus,
where it dimerizes with Arnt and activates transcription of
genes containing dioxin-response elements.
A substantial body of evidence indicates that the role
of Arnt/AhR signaling in cell biology is not restricted to
the xenobiotic response but rather extends to normal
developmental processes and tumorigenesis (reviewed in
[38]). During mouse cerebellar development, for example,
both Arnt and AhR are highly expressed in GNPs during
their active proliferation phase on postnatal days 5–6,
suggesting that Arnt might maintain GNPs and possibly
derivative medulloblastoma cells in an undifferentiated
state [39]. We do not know whether the LMD-inducing
effects of Arnt are mediated by HIF or AhR signaling.
Arguing against HIF as the relevant pathway, we could
not detect increased expression of two known HIF tran-
scription targets, vascular endothelial growth factor and
glucose transporter-1, by immunostaining sections of
Shh + Arnt–induced medulloblastomas (data not shown).
Gdi2 prevents the dissociation of GDP from Rab pro-
teins, a family of membrane-localized GTPases, which
switch between active GTP-bound and inactive GDP-
bound states. There is extensive literature to support the
general concept that Rab proteins coordinate the intra-
cellular movement of membrane vesicles (reviewed in
[40]). The function of individual Rab family members is
specified by their subcellular localization. By inhibiting
GDP release, Gdi2 maintains Rab in an inactive conform-
ation, an action that seems uncharacteristic for an onco-
protein. Nevertheless, Gdi2 has a second, more oncogenic
role as a chaperone protein, facilitating the transport of
Rab molecules from inactive reserve stores in the cytosol
to active sites in their specific membrane compartments
[41,42]. Certainly, Rab GTPases contribute directly to
cancer cell physiology. Rab25, for example, promotes
invasive, metastasis-like migration of cells by binding
α5β1 integrin molecules and directing their localization
to the tips of extending pseudopods [43].
Extrapolation of our cell culture results to the in vivo
growth of medulloblastoma supports a mechanistic scheme
whereby Arnt and Gdi2 cause shedding of cells from the
primary tumor mass into the CSF by increasing cell motility
and invasiveness. By making tumor cells competent to pro-
liferate without surface attachment, expression of Arnt and
Gdi2 would also favor the formation of suspended colonies
of cells capable of surviving in the CSF before reimplantingon a leptomeningeal surface. The ability of medulloblas-
toma cells to circumvent apoptotic programs normally
triggered by detachment from a solid surface (anoikis)
is most likely a prerequisite for LMD. This adaptive
response is analogous to that of metastasizing carcin-
oma cells, which must survive the passage through the
bloodstream before colonizing a distant organ.
We could not determine in all cases whether the pres-
ence of tumor cells in the brain stem and forebrain resulted
from direct extension from the primary tumor or dispersal
through the CSF. Nevertheless, the cell traits that empower
cells to disseminate to the spinal column (motility, invasive-
ness, and anchorage-independent growth) could also
promote extension from the cerebellum to the fourth
ventricle or remote sites in the forebrain.
We demonstrated the LMD-inducing effects of Arnt
and Gdi2 in Shh-induced medulloblastomas in vivo and
validated these effects in culture using cell lines in
which the Shh signaling pathway is active. Therefore,
we cannot conclude that Arnt and Gdi2 are LMD drivers
in Shh-independent medulloblastomas even though Arnt
and Gdi2 are expressed in all subgroups. Nevertheless, the
fact that medulloblastomas of any molecular subgroup
can metastasize, either at initial presentation or relapse,
broadens the clinical significance of LMD driver genes
discovered in different genetic backgrounds [44].
The multiple cellular transitions connecting tumor
stromal detachment, CSF passage, and finally leptomen-
ingeal spreading indicate that LMD might approach the
complexity of the invasion–metastasis model used to
describe hematogenous metastasis of epithelial cancers.
Transposon mutagenesis revealed hundreds of candidate
genes, although we do not know how many of these
genes are drivers as opposed to passengers in the LMD
process. Through the functional validation studies we
have reported here and previously [18], we know that
Shh-induced medulloblastomas can start down a path
of disseminated growth by addition of single LMD driver
genes.Additional files
Additional file 1: Figure S1. Characterization of SHH-NPD cells. A,
Immunoperoxidase staining showing expression of c-Myc–tagged Shh
(Mab 9E10). B, Western blot analysis of SHH-NPD cells. Two bands (60 and
37 kDa), corresponding to full-length Shh and carboxy-terminal peptides
derived from autoproteolysis [45], were detected with an antibody directed
against the c-Myc epitope tag of RCAS-Shh in SHH-NPD cells (lane 2), but
not in uninfected GNPs (lane 1). C, Expression of βIII-tubulin, a marker of
early neuronal differentiation. D, Absence of immunoreactive staining for
neurofilament protein, a marker of post-mitotic neurons. Scale bar, 16 μm.
Additional file 2: Figure S2. Expression of ARNT and GDI2 in human
medulloblastoma subgroups. Box plots showing relative expression of
ARNT (A) and GDI2 (B) in normal adult cerebella (CB; n = 10) and
medulloblastoma samples (n = 187) from the COG consortium profiled
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(WNT, SHH, Group 3, Group 4).
Additional file 3: Figure S3 Differential expression of ARNT and
GDI2 in matched pairs of primary and metastatic tumors from eight
medulloblastoma patients.
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